ResMed (BSP:R1MD34) 3-Year Revenue Growth Rate : 12.20% (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is ResMed 3-Year Revenue Growth Rate?

ResMed's Revenue per Share for the three months ended in Dec. 2023 was R$9.65.

During the past 12 months, ResMed's average Revenue per Share Growth Rate was 19.40% per year. During the past 3 years, the average Revenue per Share Growth Rate was 12.20% per year. During the past 5 years, the average Revenue per Share Growth Rate was 11.50% per year. During the past 10 years, the average Revenue per Share Growth Rate was 10.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of ResMed was 32.30% per year. The lowest was 7.90% per year. And the median was 15.40% per year.

Competitive Comparison of ResMed's 3-Year Revenue Growth Rate

For the Medical Instruments & Supplies subindustry, ResMed's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ResMed's 3-Year Revenue Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, ResMed's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where ResMed's 3-Year Revenue Growth Rate falls into.

ResMed 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

ResMed (BSP:R1MD34) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

ResMed 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of ResMed's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

ResMed (BSP:R1MD34) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ResMed Inc (BSP:R1MD34) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

RSMDF:USA RMD:USA RMEA:Germany RME:Germany RMEA:Germany RME:Germany RMD:Australia

Address

9001 Spectrum Center Boulevard, San Diego, CA, USA, 92123

Website

https://www.resmed.com

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.

ResMed (BSP:R1MD34) Headlines

No Headlines